Sydney, Australia (CU)_ Illuccix, a prostate cancer imaging tool developed by Telix Pharmaceuticals (TLX), has been authorized by the US Food and Drug Administration. The product is a kit for making an…

FDA approves Telix Pharmaceuticals’ prostate cancer treatment

Plants May Soon Have Their Own Health Trackers

US-Canada Trade Dispute Continues as Washington Downplays Ottawa’s Concessions on Digital Tax and Media Rules

Aviation Caught in the Storm: Sri Lankan Airlines Suspends Kuwait Flights as Middle East Tensions Escalate

Could Kenya’s New Tariffs Derail East Africa’s Free Trade Dream?

India’s First Dengue Vaccine Approved as QDENGA Gains DCGI Approval

Related Articles

India’s First Dengue Vaccine Approved as QDENGA Gains DCGI Approval

Feeling Lonely Often? Scientists Uncover the Mental Health Risks of Loneliness

New Malaria Drug Candidate MMV367 Shows Rapid Parasite Killing and Hope Against Drug Resistance

Study Finds Medicinal Cannabis Compound Could Expand Treatment Options for Drug-Resistant Childhood Epilepsy

Colon Cancer in Young Adults: Why Cases Are Climbing

BRICS expansion: five countries join, another 25 to follow in 2024

Chinese state media lauds India’s achievements under PM Modi!

Security alarm for India: Bangladesh frees Al-Qaeda terror group chief